Wave Life Sciences to Present at Jefferies London Healthcare Conference

Company Overview - Wave Life Sciences Ltd. is a clinical-stage biotechnology company focused on RNA medicines aimed at transforming human health [3] - The company utilizes its RNA medicines platform, PRISM®, which integrates various modalities and innovations in chemistry and human genetics to develop treatments for both rare and prevalent disorders [3] - Wave's pipeline includes clinical programs targeting Duchenne muscular dystrophy, Alpha-1 antitrypsin deficiency, and Huntington's disease, along with a preclinical program in obesity [3] Upcoming Events - Paul Bolno, MD, MBA, President and CEO of Wave Life Sciences, will participate in an analyst-led fireside chat at the Jefferies London Healthcare Conference on November 20, 2024, at 4:30 p.m. GMT / 11:30 a.m. ET [1] - A live webcast of the presentation will be available on the company's Investor Relations website, with a replay accessible for a limited time after the event [2]